ICON PLCNASDAQ:ICLR
- LAST PRICE329.7000
- TODAY'S CHANGE (%)1.9000 (0.5796%)
- Bid / Lots131.5000/ 2
- Ask / Lots345.9700/ 1
- Open / Previous Close328.3800 / 327.8000
- Day Range
- 52 Week Range
- Volume371,607
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ICLR |
|---|---|---|
| 02:24 ET | 100 | 328.565 |
| 02:26 ET | 300 | 328.34 |
| 02:29 ET | 120 | 328.69 |
| 02:31 ET | 444 | 328.56 |
| 02:33 ET | 300 | 328.17 |
| 02:36 ET | 200 | 328.145 |
| 02:38 ET | 742 | 328.18 |
| 02:40 ET | 342 | 328.085 |
| 02:42 ET | 100 | 328.31 |
| 02:45 ET | 100 | 328.075 |
| 02:47 ET | 1100 | 328.5 |
| 02:49 ET | 400 | 328.49 |
| 02:51 ET | 500 | 328.91 |
| 02:54 ET | 400 | 328.905 |
| 02:56 ET | 400 | 329.1 |
| 02:58 ET | 641 | 329.25 |
| 03:02 ET | 1750 | 329.1 |
| 03:03 ET | 874 | 329.2676 |
| 03:05 ET | 1516 | 329.93 |
| 03:09 ET | 100 | 329.92 |
| 03:12 ET | 600 | 330 |
| 03:14 ET | 335 | 329.95 |
| 03:16 ET | 200 | 330.13 |
| 03:18 ET | 1300 | 329.525 |
| 03:20 ET | 550 | 329.75 |
| 03:21 ET | 100 | 329.74 |
| 03:23 ET | 1637 | 329.9 |
| 03:25 ET | 1541 | 329.995 |
| 03:27 ET | 300 | 330.3 |
| 03:30 ET | 200 | 330.5 |
| 03:32 ET | 800 | 330.02 |
| 03:34 ET | 142 | 330.2299 |
| 03:36 ET | 200 | 329.885 |
| 03:38 ET | 300 | 329.57 |
| 03:39 ET | 1110 | 329.175 |
| 03:41 ET | 2553 | 329.155 |
| 03:43 ET | 1300 | 328.92 |
| 03:45 ET | 200 | 328.94 |
| 03:48 ET | 700 | 329.09 |
| 03:50 ET | 600 | 329.13 |
| 03:52 ET | 3694 | 329.295 |
| 03:54 ET | 1200 | 328.96 |
| 03:56 ET | 5682 | 329.36 |
| 03:57 ET | 1404 | 329.27 |
| 03:59 ET | 46401 | 329.7 |
Jul 10, 2024
ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer, from 7:15AM ET on Wednesday Jul 10, 2024 by Dow Jones
7:15AM ET on Wednesday Jul 10, 2024 by Dow Jones
Jul 8, 2024
DJ Icon Is Maintained at Outperform by Baird, from 12:08PM ET on Monday Jul 08, 2024 by Dow Jones
12:08PM ET on Monday Jul 08, 2024 by Dow Jones
Jul 1, 2024
Press Release: ICON plc Schedules Second Quarter 2024 Earnings Conference Call, from 5:43PM ET on Monday Jul 01, 2024 by Dow Jones
5:43PM ET on Monday Jul 01, 2024 by Dow JonesICON plc Schedules Second Quarter 2024 Earnings Conference Call, from 4:15PM ET on Monday Jul 01, 2024 by Dow Jones
4:15PM ET on Monday Jul 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ICON PLC | 27.6B | 40.0x | +4.68% |
Biogen Inc | 33.2B | 28.3x | -18.14% |
Grifols SA | 6.4B | 26.3x | --- |
Moderna Inc | 47.5B | -7.7x | --- |
Biontech SE | 20.6B | 164.3x | --- |
Incyte Corp | 14.7B | 20.0x | +39.11% |
Company Information
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Contact Information
- Headquarters
- South County Business Park LEOPARDSTOWN, Dublin 18DUBLIN, Ireland 00000
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Ciaran Murray
- Chief Executive Officer, Director
- Stephen Cutler
- Chief Financial Officer
- Brendan Brennan
- Chief Administrative Officer, General Counsel, Company Secretary
- Diarmaid Cunningham
- Lead Independent Director
- Ronan Murphy
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $27.6B |
|---|---|
Revenue (TTM) | $8.2B |
Shares Outstanding | 82.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.23 |
EPS | $8.24 |
Book Value | $112.02 |
P/E Ratio | 40.0x |
Price/Sales (TTM) | 3.4 |
Price/Cash Flow (TTM) | 21.7x |
Operating Margin | 12.45% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
